We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$2.72B
1-Year Est. Return
121.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.01%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.17B
AUM Growth
+$137M
(+13%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
23.33%
Top 10 Holdings %
Top 10 Hldgs %
50.6%
Holding
152
New
28
Increased
32
Reduced
40
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASRT
Assertio
ASRT
|
+$18.2M |
| 2 |
America's Car Mart
CRMT
|
+$13M |
| 3 |
Peloton Interactive
PTON
|
+$12.7M |
| 4 |
Zevra Therapeutics
ZVRA
|
+$11.5M |
| 5 |
Noodles & Co
NDLS
|
+$7.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Bancorp
TBBK
|
+$14M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
+$10.2M |
| 3 |
Pathward Financial
CASH
|
+$8.42M |
| 4 |
MediaAlpha
MAX
|
+$8.11M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$6.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.11% |
| 2 | Consumer Discretionary | 9.31% |
| 3 | Financials | 6.27% |
| 4 | Communication Services | 5.51% |
| 5 | Technology | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
NeuroOne Medical Technologies
NMTC
$14M
| $1.11M | 0.1% |
+208,333
| New | +$1.4M |
|
102
Rezolute
RZLT
$454M
| $1.02M | 0.09% |
769,606
| – | – |
|
103
CALL
uniQure
QURE
$3.12B
| $991K | 0.08% |
147,700
-240,000
| -62% | -$2.16M |
|
104
Journey Medical
DERM
$179M
| $955K | 0.08% |
348,663
+169,957
| +95% | +$380K |
|
|
105
The Bancorp
TBBK
$2.83B
| $859K | 0.07% |
24,896
-383,050
| -94% | -$14M |
|
|
SGRP
106
DELISTED
SPAR Group
SGRP
| $847K | 0.07% |
879,189
+121,157
| +16% | +$139K |
|
|
ACER
107
DELISTED
Acer Therapeutics Inc
ACER
| $748K | 0.06% |
918,349
-218,067
| -19% | -$179K |
|
108
Talphera
TLPH
$74.7M
| $680K | 0.06% |
+1,173,015
| New | +$1.12M |
|
|
SCTL
109
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $586K | 0.05% |
+1,250,000
| New | +$892K |
|
110
Sensus Healthcare
SRTS
$51M
| $513K | 0.04% |
185,048
| – | – |
|
|
111
CALL
Talphera
TLPH
$74.7M
| $438K | 0.04% |
+755,000
| New | +$721K |
|
112
Instil Bio
TIL
$50.7M
| $428K | 0.04% |
+50,000
| New | +$504K |
|
113
CALL
Keros Therapeutics
KROS
$212M
| $392K | 0.03% |
12,300
| – | – |
|
|
APTO
114
DELISTED
Aptose Biosciences, Inc.
APTO
| $382K | 0.03% |
4,549
-325
| -7% | -$38.3K |
|
|
LADR
115
Ladder Capital
LADR
$1.26B
| $278K | 0.02% |
27,073
| – | – |
|
116
Exagen
XGN
$167M
| $258K | 0.02% |
106,769
-15,125
| -12% | -$38.4K |
|
117
Elicio Therapeutics
ELTX
$80.6M
| $254K | 0.02% |
30,000
-64,939
| -68% | -$618K |
|
118
ADC Therapeutics
ADCT
$145M
| $231K | 0.02% |
257,162
-582,838
| -69% | -$775K |
|
119
CALL
Abeona Therapeutics
ABEO
$429M
| $219K | 0.02% |
52,000
+32,000
| +160% | +$121K |
|
120
Transact Technologies
TACT
$58.2M
| $200K | 0.02% |
31,108
-8,392
| -21% | -$63.5K |
|
121
Lucid Diagnostics
LUCD
$185M
| $185K | 0.02% |
158,135
-40,939
| -21% | -$59.4K |
|
|
BMTX
122
DELISTED
BM Technologies, Inc.
BMTX
| $158K | 0.01% |
79,212
| – | – |
|
|
AKU
123
DELISTED
Akumin Inc
AKU
| $143K | 0.01% |
979,196
-907,660
| -48% | -$145K |
|
124
Rafael Holdings
RFL
$98.8M
| $138K | 0.01% |
73,695
| – | – |
|
|
HURA
125
TuHURA Biosciences
HURA
$142M
| $91.4K | 0.01% |
+646
| New | +$95.3K |
|
Similar funds
TAM
XL
NB
PA
BCM
SCM
HCM
GC
Nantahala Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Nantahala Capital Management held 152 positions worth $1.17B, up 13% from $1.03B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Nantahala Capital Management deployed $273M of net new capital in Q3 2023, opening 28 new positions and adding to 32 existing holdings. Its largest new stake was Assertio: 311,333 shares worth $12M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was The Bancorp, an estimated $14M trimmed.
- Nantahala Capital Management's largest Q3 2023 buy was Assertio: 311,333 shares worth $12M.
- Nantahala Capital Management added most to America's Car Mart in Q3 2023, an estimated $13M increase.
- Nantahala Capital Management's biggest Q3 2023 reduction was The Bancorp, cutting an estimated $14M.
- Nantahala Capital Management fully exited Autolus Therapeutics in Q3 2023, selling an estimated $10.2M.
- Nantahala Capital Management's ten largest holdings make up 51% of its $1.17B portfolio in Q3 2023.
- Nantahala Capital Management opened 28 new positions and closed 19 in Q3 2023.
- Nantahala Capital Management's portfolio value rose 13% quarter-over-quarter to $1.17B.
Based on Nantahala Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.